Subscribe

254 - Celgene

Courtesy of Celgene Corporation

The biopharmaceutical company is the maker of Thalomid and various other drugs that treat multimple myeloma, inflammatory diseases, and various forms of cancer.

Read more!

Key Metrics & Financials (Last Fiscal Year)

Revenues ($M)$11229
Revenue Percent Change21.3%
Profits ($M)$1,999.2
Profits Percent Change24.8%
Assets ($M)$28086
Market Value — as of March 31, 2017 ($M)$96,802
Employees7,132
Previous Rank305

Company Facts

Employees7,132
SectorHealth Care
IndustryPharmaceuticals
HQ LocationSummit, NJ
CEOMark J. Alles
CEO Title-
Websitewww.celgene.com
Years on Fortune 500 List6

See Full List

Outbrain
Read more!